Search

Alfred F Altomari

from Lawrenceville, NJ
Deceased
Get Report
Related to:
Laurie Ann Altomari, 52Frank Joseph Altomari, 54Frank J AltomariGregory A Kibbee, 62Nanette Kibbee, 65Stephanie L Hearn, 37James Lavelle, 68John Lavelle, 73
Connected to:
Alfred Altomari, 66Barbara J Altomare, 93Benjamin M Altomari, 44Diane P Altomari, 72Dolores Altomare, 92Edward Altomare, 78Elena Altomare, 61Mark D Altomare, 65Marla J Altomari, 52Melissa V Altomare, 72

Alfred Altomari Phones & Addresses

  • 8 Yeger Dr, Lawrenceville, NJ 08648 (609) 895-1016
  • Lawrence Township, NJ
  • 7128 Edmund St, Philadelphia, PA 19135 (215) 332-0767
  • Long Beach Township, NJ
  • Saint Charles, MO
  • 7128 Edmund St, Philadelphia, PA 19135 (215) 962-7816

Work

Position: Production Occupations

Education

Degree: High school graduate or higher

Emails

c***[email protected]

Business Records

Name / Title
Company / Classification
Phones & Addresses
Alfred Altomari
CEO
Stiefel Laboratories Inc
Research & Development in Biotechnology
600 College Rd E #3200, Princeton, NJ 08540
(609) 945-1200, (609) 945-1212
Alfred Altomari
President, Chief Executive Officer
Agile Therapeutics Inc
Medical Research and Development · Internist · Obgyn
101 Poor Farm Rd, Princeton, NJ 08540
366 Wall St, Princeton, NJ 08540
(609) 683-1880

Publications

Us Patents

Dermal Delivery Compositions And Methods

View page
US Patent:
20130116222, May 9, 2013
Filed:
Nov 2, 2012
Appl. No.:
13/667632
Inventors:
Charles G. ARNOLD - Kinnelon NJ, US
Agis KYDONIEUS - Kendall Park NJ, US
Thomas M. ROSSI - Stockton NJ, US
Alfred F. ALTOMARI - Lawrenceville NJ, US
International Classification:
A61K 31/567
US Classification:
514178
Abstract:
A composition for transdermal delivery of a progestin for progestin hormone therapy is disclosed. Also disclosed is a transdermal delivery device comprising the composition. For progestin-only hormone therapy, the composition contains an anti-oxidant and does not contain an estrogen. For therapy involving a progestin and an estrogen, the composition contains the progestin, the estrogen and an additional anti-oxidant. Methods of improving the stability of progestin-containing compositions comprising oxidative agents are also disclosed. The methods comprise including one or more anti-oxidants in the compositions.

Dermal Delivery Compositions And Methods

View page
US Patent:
20180325916, Nov 15, 2018
Filed:
Jul 25, 2018
Appl. No.:
16/045338
Inventors:
- Princeton NJ, US
Agis Kydonieus - Kendall Park NJ, US
Thomas M. Rossi - Portsmouth NH, US
Alfred F. Altomari - Lawrenceville NJ, US
Assignee:
Agile Therapeutics, Inc. - Princeton NJ
International Classification:
A61K 31/567
A61K 47/20
A61K 47/32
A61K 31/57
A61K 47/12
A61K 9/00
A61K 9/70
Abstract:
A composition for transdermal delivery of a progestin for progestin hormone therapy is disclosed. Also disclosed is a transdermal delivery device comprising the composition. For progestin-only hormone therapy, the composition contains an anti-oxidant and does not contain an estrogen. For therapy involving a progestin and an estrogen, the composition contains the progestin, the estrogen and an additional anti-oxidant. Methods of improving the stability of progestin-containing compositions comprising oxidative agents are also disclosed. The methods comprise including one or more anti-oxidants in the compositions.

Dermal Delivery Compositions And Methods

View page
US Patent:
20160250226, Sep 1, 2016
Filed:
May 11, 2016
Appl. No.:
15/151966
Inventors:
- Princeton NJ, US
Agis KYDONIEUS - Kendall Park NJ, US
Thomas M. ROSSI - Stockton NJ, US
Alfred F. ALTOMARI - Lawrenceville NJ, US
Assignee:
Agile Therapeutics, Inc. - Princeton NJ
International Classification:
A61K 31/567
A61K 47/12
A61K 47/20
A61K 47/32
A61K 9/00
A61K 9/70
Abstract:
A composition for transdermal delivery of a progestin for progestin hormone therapy is disclosed. Also disclosed is a transdermal delivery device comprising the composition. For progestin-only hormone therapy, the composition contains an anti-oxidant and does not contain an estrogen. For therapy involving a progestin and an estrogen, the composition contains the progestin, the estrogen and an additional anti-oxidant. Methods of improving the stability of progestin-containing compositions comprising oxidative agents are also disclosed. The methods comprise including one or more anti-oxidants in the compositions.
Control profile
Alfred F Altomari from Lawrenceville, NJDeceased Get Report